People most vulnerable to Omicron would reportedly be offered experimental pill within 48 hours of testing positive
Molnupiravir is marketed as Lagevrio.The first at-home treatment for Covid-19 could reportedly be offered to UK patients before Christmas as an attempt to protect the most vulnerable from the Omicron variant.Molnupiravir antiviral pill, marketed as LagevrioThe newspaper said that under the plans, the NHS was expected to deliver courses of the tablet to clinically vulnerable and immunosuppressed patients within as little as 48 hours of them testing positive for Covid.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
UK travel rules tightened as Covid omicron cases riseSajid Javid orders pre-departure tests for all travellers to UK, regardless of vaccination status
Weiterlesen »
New Covid drug that cuts death by 80% approved in UK amid fight against OmicronA NEW Covid drug that cuts the risk of death by nearly 80 per cent has been approved in the UK amid the fight against Omicron. Xevudy (Sotrovimab) was given the green light as it’s been …
Weiterlesen »
COVID-19: At least 50 people infected with Omicron variant at Christmas party in NorwayThe news comes as Norway joins a number of other countries trying to control the spread of the variant with tougher rules.
Weiterlesen »
Covid: First data points to Omicron re-infection riskScientists in South Africa have identified a spike in the numbers catching Covid again.
Weiterlesen »